Curis
CRIS
#11032
Rank
HK$47.47 M
Marketcap
HK$7.11
Share price
6.65%
Change (1 day)
-30.23%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): -HK$78.38

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$111.50. In 2022 the company made an earnings per share (EPS) of -HK$95.66 a decrease over its 2021 EPS that were of -HK$78.41.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$78.38-18.07%
2022-HK$95.6622%
2021-HK$78.41-25.37%
2020-HK$105.07-30.93%
2019-HK$152.12-2.02%
2018-HK$155.26-37.38%
2017-HK$247.94-29.73%
2016-HK$352.86-10%
2015-HK$392.07138.1%
2014-HK$164.6740%
2013-HK$117.62-25%
2012-HK$156.8366.67%
2011-HK$94.10-850%
2010HK$12.55-114.29%
2009-HK$87.82-26.07%
2008-HK$118.80-26.28%
2007-HK$161.148.44%
2006-HK$148.59-32.68%
2005-HK$220.73-3.76%
2004-HK$229.3662.95%
2003-HK$140.75-93.86%
2002-HK$2,29239.5%
2001-HK$1,643

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$27.13-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.94-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$26.97-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA